SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-001751
Filing Date
2019-03-04
Accepted
2019-03-04 16:47:18
Documents
1
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-44352.html 4  
1 PRIMARY DOCUMENT marketforms-44352.xml 4 3990
  Complete submission text file 0001214659-19-001751.txt   5392
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Boyd Peter E. (Reporting) CIK: 0001739816 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 19654531